"This JDA underscores our commitment to advancing cutting-edge solutions that leverage our unique ceramic technology, which holds the potential to reshape the landscape of oncological therapies.” "SINTX’s expertise in advanced ceramic processing has facilitated the development of CombiSphere, a next generation, radio-labeled microsphere with differentiated properties, including radiopacity to facilitate new dosimetry modalities and a unique physical structure that allows high per-particle radiation activity at a density similar to red blood cells,” said Richard Yazebeck, President, CEO, and Co-Founder of NED Medical. "Equally exciting, and only achievable because of the material composition and manufacturing process, is that every microsphere in a dose is both radiopaque and radiation-emitting.” "Our partnership and collaboration with SINTX has transformed the trajectory of NED Medical and has positioned us to provide a unique solution to the clinical community.
Salt Lake City, UT, Nov.21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc.(NASDAQ: SINT) ("SINTX” or the "Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announces the signing of a Joint Development Agreement (JDA) with NED Medical Inc., an innovative developer of oncology embolization therapy technologies.
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulty in commercializing ceramic technologies and development of new product opportunities.
The story "SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment" has 853 words across 25 sentences, which will take approximately 4 - 8 minutes for the average person to read.
Which news outlet covered this story?
The story "SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment" was covered 20 hours ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 82 news stories per day.
It's most recent story was published 9 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Negative, indicating that people regard this as "bad news".
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
